Clinical Trial Update: A Study of RSLV-132 in Females With Sjögren's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating RSLV-132 in females with Primary Sjögren's syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• RSLV-132

Snippet

Sponsor: Resolve Therapeutics | Conditions: Primary Sjögren Syndrome | Phase 2 | Status: RECRUITING